BIOMARIN PHARMACEUTICAL INC Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for the quarter ending 2016-09-30 was $26.48M.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for the quarter ending 2016-06-30 was $13.45M.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for the quarter ending 2016-03-31 was $3.52M.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for fiscal 2015 was $53.09M, a 25.43% decline from fiscal 2014.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for fiscal 2014 was $71.19M, a 8.29% increase from fiscal 2013.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for fiscal 2013 was $65.74M, a 15.25% decline from fiscal 2012.
- BIOMARIN PHARMACEUTICAL INC stock issued during period, value, stock options exercised for fiscal 2012 was $77.57M, a 161.06% increase from fiscal 2011.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2016-09-30 | $26.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | |
| 2016-06-30 | $13.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | |
| 2016-03-31 | $3.52M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $53.09M 10-K · filed 2016-02-29 | |
| 2014-12-31 | $71.19M 10-K · filed 2016-02-29 | |
| 2013-12-31 | $65.74M 10-K · filed 2016-02-29 | |
| 2012-12-31 | $77.57M 10-K · filed 2015-03-02 | |
| 2011-12-31 | $29.71M 10-K · filed 2014-02-26 | |
| 2010-12-31 | $29.46M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $7.66M 10-K · filed 2012-02-22 | |
| 2008-12-31 | $25.82M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |